FROM THE EDITOR
Welcome to the Chronic Lymphocytic Leukemia Resource Center! Take a look around and find current information, news, literature, and other resources from this area of oncology treatment. We hope this site is helpful to your practice. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.
Amber Koehler, PA-C
Mayo Clinic
Rochester, Minnesota
Resources
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia
A041202 Trial - NEJM
CLL Society - CLL-specific Patient Support Groups
iwCLL Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management of CLL
E1912 Trial - NEJM
News & Literature Highlights